Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Current Pharmaceutical Design
|
November 11, 2008
A scientific approach to anti-ageing therapies: state of the art
E Jirillo, G Candore, T Magrone, et al.
Cancer Gene Therapy
|
January 11, 2014
Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments
C R Balistreri, G Candore, D Lio, et al.
European Journal of Cell Biology
|
December 24, 1997
Phenoloxidase-dependent cytotoxic mechanism in ascidian (Styela plicata) hemocytes active against erythrocytes and K562 tumor cells
M Cammarata, V Arizza, N Parrinello, et al.
Current Pharmaceutical Design
|
April 15, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement
G Candore, C Caruso, E Jirillo, et al.
Immunopharmacology and Immunotoxicology
|
January 1, 1991
HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2
G Candore, A T Colucci, M A Modica, et al.
Immunobiology
|
November 1, 1990
Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals
M A Modica, A M Zambito, G Candore, et al.
Current Pharmaceutical Design
|
November 11, 2008
Polyphenols from red wine modulate immune responsiveness: biological and clinical significance
T Magrone, G Candore, C Caruso, et al.
HLA
|
June 8, 2018
Autoimmune diseases and 8.1 ancestral haplotype: An update
C M Gambino, A Aiello, G Accardi, et al.
Disease Markers
|
March 1, 1992
IgD serum levels are influenced by HLA-DR phenotype
D Lio, G Candore, A T Colucci, et al.
Experimental and Clinical Immunogenetics
|
January 1, 1994
Viral antibody titers are influenced by HLA-DR2 phenotype
D Lio, N Caccamo, C D'Anna, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Current Pharmaceutical Design
|
November 11, 2008
A scientific approach to anti-ageing therapies: state of the art
E Jirillo, G Candore, T Magrone, et al.
Cancer Gene Therapy
|
January 11, 2014
Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments
C R Balistreri, G Candore, D Lio, et al.
European Journal of Cell Biology
|
December 24, 1997
Phenoloxidase-dependent cytotoxic mechanism in ascidian (Styela plicata) hemocytes active against erythrocytes and K562 tumor cells
M Cammarata, V Arizza, N Parrinello, et al.
Current Pharmaceutical Design
|
April 15, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement
G Candore, C Caruso, E Jirillo, et al.
Immunopharmacology and Immunotoxicology
|
January 1, 1991
HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2
G Candore, A T Colucci, M A Modica, et al.
Immunobiology
|
November 1, 1990
Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals
M A Modica, A M Zambito, G Candore, et al.
Current Pharmaceutical Design
|
November 11, 2008
Polyphenols from red wine modulate immune responsiveness: biological and clinical significance
T Magrone, G Candore, C Caruso, et al.
HLA
|
June 8, 2018
Autoimmune diseases and 8.1 ancestral haplotype: An update
C M Gambino, A Aiello, G Accardi, et al.
Disease Markers
|
March 1, 1992
IgD serum levels are influenced by HLA-DR phenotype
D Lio, G Candore, A T Colucci, et al.
Experimental and Clinical Immunogenetics
|
January 1, 1994
Viral antibody titers are influenced by HLA-DR2 phenotype
D Lio, N Caccamo, C D'Anna, et al.
Page
of 8